Changes in blood B cell-activating factor (BAFF) levels in multiple sclerosis : a sign of treatment outcome
author
Kannel, Karin
Alnek, Kristi
Vahter, Liina
Gross-Paju, Katrin
Uibo, Raivo
Kisand, Kalle V.
statement of authorship
Karin Kannel, Kristi Alnek, Liina Vahter, Katrin Gross-Paju, Raivo Uibo, Kalle V. Kisand
source
PLoS ONE
publisher
Public Library of Science
journal volume number month
vol. 10, 11
year of publication
2015
pages
art. e0143393
url
https://doi.org/10.1371/journal.pone.0143393
subject term
biomarkerid
multiskleroos
vereanalüüsid
keyword
B-cell activating factor
biomarkers
inflammation mediators
methylprednisolone
multiple sclerosis
reatment outcome
ISSN
1932-6203
notes
Bibliogr.: 46 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
Scopus
https://www.scopus.com/sourceid/10600153309
https://www.scopus.com/record/display.uri?eid=2-s2.0-84957921535&origin=inward&txGid=5db203bd44159c5ab06c83914eefa482
WOS
https://jcr.clarivate.com/jcr-jp/journal-profile?journal=PLOS%20ONE&year=2015
https://www.webofscience.com/wos/woscc/full-record/WOS:000365853900105
category (general)
Multidisciplinary
Multidistsiplinaarne
category (sub)
Multidisciplinary. Multidisciplinary
Multidistsiplinaarne. Multidistsiplinaarne
quartile
Q1
TalTech department
kliinilise meditsiini instituut
language
inglise